• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Furosemide, an Old Friend of Nephrologists for the Treatment of CKD: Time to Rethink the Relationship?

作者信息

Bertocchio Jean-Philippe

机构信息

Thyroid-Endocrine Tumors, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, Paris, France.

出版信息

Kidney Int Rep. 2025 May 17;10(7):2094-2096. doi: 10.1016/j.ekir.2025.05.021. eCollection 2025 Jul.

DOI:10.1016/j.ekir.2025.05.021
PMID:40677316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12266250/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ecc/12266250/b8435d8e4180/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ecc/12266250/b8435d8e4180/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ecc/12266250/b8435d8e4180/gr1.jpg

相似文献

1
Furosemide, an Old Friend of Nephrologists for the Treatment of CKD: Time to Rethink the Relationship?速尿，肾脏病学家治疗慢性肾脏病的老朋友：是时候重新审视这种关系了？
Kidney Int Rep. 2025 May 17;10(7):2094-2096. doi: 10.1016/j.ekir.2025.05.021. eCollection 2025 Jul.
2
Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists.来自一项关于意大利肾病学家对慢性肾脏病相关骨质疏松症管理的全国性调查的真实世界数据。
Arch Osteoporos. 2025 Jul 16;20(1):96. doi: 10.1007/s11657-025-01570-z.
3
'We are somehow fixated on this being a diabetes drug': a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation.我们似乎对这种药物是一种糖尿病药物这一观点有些执迷不悟：一项定性研究探讨了心脏病专家和肾病专家对钠-葡萄糖共转运蛋白 2 抑制剂起始治疗的看法。
Intern Med J. 2024 Apr;54(4):559-567. doi: 10.1111/imj.16203. Epub 2023 Aug 7.
4
Furosemide and albumin for the treatment of nephrotic edema: a systematic review.速尿和白蛋白治疗肾病性水肿：系统评价。
Pediatr Nephrol. 2022 Aug;37(8):1747-1757. doi: 10.1007/s00467-021-05358-4. Epub 2022 Mar 3.
5
Perceptions of high-sensitivity C-reactive protein testing (hsCRP) in atherosclerotic cardiovascular disease: a US survey on cardiologists and nephrologists.关于高敏C反应蛋白检测（hsCRP）在动脉粥样硬化性心血管疾病中的认知：一项针对美国心脏病专家和肾病专家的调查
Future Cardiol. 2025 Jul;21(9):701-710. doi: 10.1080/14796678.2025.2514349. Epub 2025 Jun 3.
6
Nephrologists' perspectives and experiences with hospice among older adults with end-stage kidney disease.肾病学家对老年终末期肾病患者临终关怀的看法和经验。
J Am Geriatr Soc. 2024 Jul;72(7):2060-2069. doi: 10.1111/jgs.18936. Epub 2024 May 22.
7
Investigational new drugs for the treatment of chronic renal failure: an overview of the literature.治疗慢性肾衰竭的新药：文献综述。
Expert Opin Investig Drugs. 2024 Apr;33(4):319-334. doi: 10.1080/13543784.2024.2326624. Epub 2024 Mar 28.
8
Loop diuretics for patients receiving blood transfusions.用于接受输血患者的袢利尿剂。
Cochrane Database Syst Rev. 2015 Feb 16;2015(2):CD010138. doi: 10.1002/14651858.CD010138.pub2.
9
Pediatric Nephrology Practice in the United States: Survey of Pediatric Nephrology Division Directors.美国儿科肾脏病学实践：儿科肾脏病学部门主任调查
Am J Kidney Dis. 2025 Jul;86(1):74-83. doi: 10.1053/j.ajkd.2025.01.025. Epub 2025 Apr 4.
10
Furosemide for transient tachypnoea of the newborn.速尿用于新生儿短暂性呼吸急促。
Cochrane Database Syst Rev. 2013 Jun 5(6):CD003064. doi: 10.1002/14651858.CD003064.pub2.

引用本文的文献

1
Response to the Letter to the Editor Entitled "Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits".对题为《优化晚期慢性肾脏病中呋塞米的使用：权衡风险与获益》的致编辑信的回复
Kidney Int Rep. 2025 Jun 3;10(8):2877-2878. doi: 10.1016/j.ekir.2025.05.048. eCollection 2025 Aug.
2
Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits.优化晚期慢性肾脏病中呋塞米的使用：权衡风险与获益
Kidney Int Rep. 2025 Jun 3;10(8):2877. doi: 10.1016/j.ekir.2025.05.047. eCollection 2025 Aug.

本文引用的文献

1
Comprehensive analysis of a widely pharmaceutical, furosemide, and its degradation products in aquatic systems: Occurrence, fate, and ecotoxicity.全面分析在水生态系统中广泛存在的药物：呋塞米及其降解产物：环境行为、归趋和生态毒性。
Environ Pollut. 2024 May 1;348:123799. doi: 10.1016/j.envpol.2024.123799. Epub 2024 Mar 23.
2
Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.慢性肾脏病患者血清犬尿氨酸水平与心血管结局及全因死亡率之间的关联研究。
Clin Kidney J. 2023 Sep 28;17(1):sfad248. doi: 10.1093/ckj/sfad248. eCollection 2024 Jan.
3
Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
静脉注射呋塞米与新型 pH 中性呋塞米皮下制剂在门诊心力衰竭恶化患者中的疗效比较。
JACC Heart Fail. 2018 Jan;6(1):65-70. doi: 10.1016/j.jchf.2017.10.001. Epub 2017 Dec 6.
4
A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.一项关于呋塞米与氢氯噻嗪治疗慢性肾衰竭合并高血压患者的随机试验。
Nephrol Dial Transplant. 2005 Feb;20(2):349-53. doi: 10.1093/ndt/gfh650. Epub 2004 Dec 22.
5
EXPERIENCES WITH FUROSEMIDE IN RENAL DISEASE.呋塞米在肾脏疾病中的应用经验
Proc Soc Exp Biol Med. 1965 Feb;118:333-6. doi: 10.3181/00379727-118-29835.
6
A NEW EFFECTIVE DIURETIC--LASIX.一种新型高效利尿剂——速尿。
Br Med J. 1964 Oct 10;2(5414):910-4. doi: 10.1136/bmj.2.5414.910.
7
Alternatively spliced isoform of apical Na(+)-K(+)-Cl(-) cotransporter gene encodes a furosemide-sensitive Na(+)-Cl(-)cotransporter.顶端钠-钾-氯协同转运蛋白基因的可变剪接异构体编码一种对呋塞米敏感的钠-氯协同转运蛋白。
Am J Physiol Renal Physiol. 2001 Apr;280(4):F574-82. doi: 10.1152/ajprenal.2001.280.4.F574.